MALAT1 and hepatocellular carcinoma: For instance, the TGFBR1 inhibitor galunisertib can block VEGF synthesis [110], while MALAT1 was observed to enhance VEGF production via inhibiting miR-140 and promoted angiogenesis of HUVECs in HCC [111].